 BURNABY, British Columbia, March 29, 2021 GLOBE NEWSWIRE -- Xenon Pharmaceuticals Inc. Nasdaq:XENE, a clinical stage biopharmaceutical company, today announced that the Company will participate in a fireside chat at the following virtual investor conference: 